Insulet (PODD) excels with strong Q2 results, Omnipod 5 app launch, and >20% growth outlook. Read here for an investment ...

Abercrombie & Fitch shows potential despite economic pressures, tariffs, and brand challenges. Read here for more analysis on ...

Weyco (WEYS) stock's 2Q25 earnings reveal revenue and margin struggles across brands. See more on key challenges, tariff ...

USRT ETF is rated as a hold. Read more on its diversified exposure, low volatility, and resilience, yet limited growth appeal ...

Globally diversified core strategy based on the Global Perspectives unique investment philosophy and built with Voya’s suite ...

Arkema boosts cost-saving target to €100M, tightens controls, and offers attractive valuation for long-term investors. See ...

The Trusts’ primary performance objective is to outperform its strategic allocation composite benchmark over the long-term ...

Coloplast faces declining growth and margins, with operational issues and weak demand. Read here for an analysis of CLPBY ...

For the quarter, Voya Infrastructure, Industrials And Materials Fund provided a total return of 10.57% on a net asset value ...

BXP's pullback offers a buying opportunity with improving trends, a 6.3% yield, and potential upside. Read here for more on ...

Starwood Property's Q2 earnings fall short of dividend coverage for the second quarter. See more on STWD's risks, ...

Rush Enterprises thrives in the cyclical commercial vehicle industry, maintaining profitability through downturns. Read more ...